FDA Approved: VIZIMPRO — Original Application (U.S. Pharmaceuticals)

View source ↗

Summary

FDA approved VIZIMPRO (dacomitinib) under an Original Application (NDA) from U.S. Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• VIZIMPRO (dacomitinib)

Snippet

ORIG AP for VIZIMPRO (DACOMITINIB)